Experimental and Clinical Nephroprotection by the Xanthine Oxidase Inhibitor Febuxostat

Naunyn-Schmiedeberg's Archives of Pharmacology - Germany
doi 10.1007/s00210-016-1260-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Development of Nonalcoholic Steatohepatitis in a Rodent Model

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2015English

The Xanthine Oxidase Inhibitor Febuxostat Reduces Tissue Uric Acid Content and Inhibits Injury-Induced Inflammation in the Liver and Lung

European Journal of Pharmacology
Pharmacology
2015English

Inhibition of Xanthine Oxidase and Xanthine Dehydrogenase by Nitric Oxide

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Xanthine Dehydrogenase/Xanthine Oxidase and Oxidative Stress

AGE
1997English

The Molybdenum Centers of Xanthine Oxidase and Xanthine Dehydrogenase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

The Specificity of Xanthine Oxidase

Biochemical Journal
1938English

Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options

Seminars in Nephrology
Nephrology
2011English

Enantioselective Uptake of BOF-4272, a Xanthine Oxidase Inhibitor With a Chiral Sulfoxide, by Isolated Rat Hepatocytes.

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2001English

The Identity of Xanthine Oxidase and the Schardinger Enzyme

Biochemical Journal
1935English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy